About Wake Research
Wake Research is a company based in Raleigh (United States) founded in 1984 was acquired by M3 in February 2018. The company has 68 employees as of December 31, 2020. Wake Research has completed 2 acquisitions, including Multi-Specialty Research Associates and Pharmacology Research Institute. Wake Research operates in a competitive market with competitors including Elligo, Acurian, Inclinix, CenExel and ePatientFinder, among others.
- Headquarter Raleigh, United States
- Employees 68 as on 31 Dec, 2020
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name M3 Wake Research, Inc.
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
Not available
- Investors
-
Employee Count
68
as on Dec 31, 2020
-
Investments & Acquisitions
Multi-Specialty Research Associates
& 1 more
-
Acquired by
M3
(Feb 01, 2018)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Wake Research
Detailed funding history for Wake Research
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investors in Wake Research
Wake Research has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include m3.com.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Japan's members-only networking site for healthcare professionals is operated.
|
Locked | Locked | Locked |
Investor details for Wake Research
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Wake Research
Wake Research has strategically engaged in corporate development activities, having acquired 2 companies. Notable acquisitions include Multi-Specialty Research Associates and Pharmacology Research Institute.
Investment portfolio details for Wake Research
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Clinical site management organization
|
Locked | Locked | 2016 | Locked | |
|
Clinical services are provided by the medical research lab.
|
Locked | Locked | 1975 | Locked |
Complete acquisition details for Wake Research
Transaction dates, acquired stakes, disclosed values, domains, and locations require an active premium plan.
- Transaction dates
- Acquired stakes
- Disclosed values
- Domains and locations
Verified entity values are shown only after access is granted.
Financial Statements - Wake Research
Detailed financials for Wake Research
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Wake Research Comparisons
Peer comparison for Wake Research
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Wake Research
Wake Research operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Elligo, Acurian, Inclinix, CenExel and ePatientFinder, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Patient recruitment and site activation services are provided by Elligo.
|
|
| Locked | Locked | Locked |
Patient enrollment and retention solutions for clinical trials are offered.
|
|
| Locked | Locked | Locked |
Customized solutions for clinical trial enrollment are provided.
|
|
| Locked | Locked | Locked |
Research site management and patient recruitment services are provided.
|
|
| Locked | Locked | Locked |
Clinical trial recruitment service company
|
|
| Locked | Locked | Locked |
Provider of site management and patient recruitment services
|
Detailed competitors of Wake Research
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Wake Research
Complete news archive for Wake Research
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Wake Research
Wake Research was founded in 1984.
Wake Research is headquartered in Raleigh, United States. It is registered at Raleigh, North Carolina, United States.
As of Dec 31, 2020, the latest employee count at Wake Research is 68.
Wake Research was founded in 1984 and is headquartered in Raleigh, United States. Clinical trials from phase I to IV are conducted across indications including dermatology, endocrinology, pulmonology, and neurology. Services encompass site management, patient recruitment, and retention for pharmaceutical clients such as Eli Lilly, Gilead, Novartis, and Bayer. Operations focus on supporting drug development in the healthcare sector.
Wake Research's top competitors include Velocity Clinical Research, Elligo and Acurian.
Wake Research has made 2 acquisitions, including Multi-Specialty Research Associates, and Pharmacology Research Institute.
Wake Research has 1 investor. Key investors include m3.com.